ZA892023B - Orally administered pharmaceutical agent for iron and magnesium substitutive therapy - Google Patents
Orally administered pharmaceutical agent for iron and magnesium substitutive therapyInfo
- Publication number
- ZA892023B ZA892023B ZA892023A ZA892023A ZA892023B ZA 892023 B ZA892023 B ZA 892023B ZA 892023 A ZA892023 A ZA 892023A ZA 892023 A ZA892023 A ZA 892023A ZA 892023 B ZA892023 B ZA 892023B
- Authority
- ZA
- South Africa
- Prior art keywords
- magnesium
- iron
- compound
- pharmaceutical agent
- orally administered
- Prior art date
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title abstract 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title abstract 3
- 239000011777 magnesium Substances 0.000 title abstract 3
- 229910052749 magnesium Inorganic materials 0.000 title abstract 3
- 229910052742 iron Inorganic materials 0.000 title abstract 2
- 239000008177 pharmaceutical agent Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 239000012736 aqueous medium Substances 0.000 abstract 2
- 150000002506 iron compounds Chemical class 0.000 abstract 2
- 150000002681 magnesium compounds Chemical class 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 229940043430 calcium compound Drugs 0.000 abstract 1
- 150000001674 calcium compounds Chemical class 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- -1 chlorine ions Chemical class 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008024 pharmaceutical diluent Substances 0.000 abstract 1
- 239000008063 pharmaceutical solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3809625A DE3809625A1 (de) | 1988-03-22 | 1988-03-22 | Oral verabreichbares pharmazeutisches mittel, insbesondere zur eisen- und magnesiumsubstitutionstherapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA892023B true ZA892023B (en) | 1989-11-29 |
Family
ID=6350387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA892023A ZA892023B (en) | 1988-03-22 | 1989-03-16 | Orally administered pharmaceutical agent for iron and magnesium substitutive therapy |
Country Status (8)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4201504C2 (de) * | 1992-01-21 | 1997-04-30 | Protina Chemische Ges Mbh | Magnesiumpräparat |
| DE19504936C1 (de) * | 1995-02-15 | 1996-05-15 | Woerwag Pharma Gmbh | Arzneimittel auf der Grundlage von Magnesiumchlorid |
| AU772891B2 (en) | 1998-12-11 | 2004-05-13 | Nostrum Pharmaceuticals, Inc. | Sustained release tablet containing hydrocolloid and cellulose ether |
| US6887897B2 (en) | 2001-07-31 | 2005-05-03 | Mission Pharmacal Company | Calcium glutarate supplement and phosphorus binder |
| US6579905B1 (en) * | 2001-11-19 | 2003-06-17 | Mcmains Michael B. | Method for the prevention or treatment of hypomagnesemia in pediatric patients and in patients with G-tubes or NG-tubes |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH294891A (de) * | 1949-06-30 | 1953-11-30 | Hilppa Pirhonen | Verfahren zur Herstellung von Nährsalzpräparaten. |
| JPS57156419A (en) * | 1981-03-24 | 1982-09-27 | Kyowa Chem Ind Co Ltd | Remedy for sideropenia |
| DE3238118A1 (de) * | 1982-10-14 | 1984-04-19 | Verla-Pharm, Arzneimittelfabrik Apotheker H.J. v. Ehrlich GmbH & Co KG, 8132 Tutzing | Verfahren zur herstellung von komplexverbindungen aus aminodicarbonsaeuren, zweiwertigen metallionen und halogenidionen |
| JPS606619A (ja) * | 1983-06-27 | 1985-01-14 | Kyowa Chem Ind Co Ltd | 鉄分欠乏症処置剤及びその製法 |
| US4751085A (en) * | 1984-08-29 | 1988-06-14 | Gaull Gerald E | Human nutritional compositions containing taurine and vitamins and/or minerals |
-
1988
- 1988-03-22 DE DE3809625A patent/DE3809625A1/de active Granted
-
1989
- 1989-03-09 DK DK115789A patent/DK115789A/da not_active Application Discontinuation
- 1989-03-14 ES ES89104529T patent/ES2072270T3/es not_active Expired - Lifetime
- 1989-03-14 AT AT89104529T patent/ATE123416T1/de not_active IP Right Cessation
- 1989-03-14 EP EP89104529A patent/EP0334177B1/de not_active Expired - Lifetime
- 1989-03-14 DE DE58909272T patent/DE58909272D1/de not_active Expired - Fee Related
- 1989-03-15 US US07/323,993 patent/US5143732A/en not_active Expired - Fee Related
- 1989-03-16 ZA ZA892023A patent/ZA892023B/xx unknown
- 1989-03-22 PT PT90096A patent/PT90096B/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE58909272D1 (de) | 1995-07-13 |
| US5143732A (en) | 1992-09-01 |
| ES2072270T3 (es) | 1995-07-16 |
| DK115789A (da) | 1989-09-23 |
| EP0334177A3 (en) | 1990-05-30 |
| PT90096A (pt) | 1989-11-10 |
| DK115789D0 (da) | 1989-03-09 |
| DE3809625A1 (de) | 1989-10-05 |
| PT90096B (pt) | 1994-10-31 |
| EP0334177A2 (de) | 1989-09-27 |
| ATE123416T1 (de) | 1995-06-15 |
| DE3809625C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-03-22 |
| EP0334177B1 (de) | 1995-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2584192A (en) | Bone-growth-stimulating composition | |
| EP0449247A3 (en) | Pharmaceutical composition containing galanthamine for treating alcoholism | |
| WO1997049373A3 (en) | Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin | |
| IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
| KR930007441A (ko) | 의약품 | |
| CA2004239A1 (en) | Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment | |
| CA2125662A1 (en) | Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis | |
| MY111260A (en) | Pharmaceutical composition for the treatment of nicotine dependence | |
| SE9002500L (sv) | Farmaceutisk, nac-innehaallande komposition foer oral administrering | |
| ATE99172T1 (de) | Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung. | |
| CA2135614A1 (en) | Use of urodilatin in pulmonary and bronchial diseases | |
| CA2042972A1 (en) | Treatment of ocular hypertension with a synergistic combination for ocular administration | |
| ZA892023B (en) | Orally administered pharmaceutical agent for iron and magnesium substitutive therapy | |
| AU8687391A (en) | Lithium treatment | |
| ZA925146B (en) | Pharmaceutical agent for treatment of withdrawal symptoms. | |
| CA2295108A1 (en) | Method of enhancing magnesium absorption and prevention of atherosclerosis | |
| HUT63058A (en) | Process for producing pharmaceutical compositions for treating osteoporosis, comprising pharmaceutically applicable alkalinizing potassium salt | |
| AU536582B2 (en) | Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends | |
| SI0797997T1 (en) | Use of peptidic bradykinin antagonists for the preparation of medicaments | |
| EP0256385A3 (de) | Verwendung von 15-Deoxyspergualin als Arzneimittel | |
| HU9403384D0 (en) | Use of (e)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatement of alzheimers`s disease | |
| KR880009652A (ko) | 3-5-디클로로메토트랙세이트를 사용하는 류마티스성 관절염 치료법 및 그에 유용한 조성물 | |
| IT1271354B (it) | Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi | |
| IT1267664B1 (it) | Composizione a base di fosfocreatina e suo uso farmaceutico | |
| RU2004224C1 (ru) | Способ обезболивани при офтальмологических операци х |